Health products

Our expertise

Magenta has unique expertise encompassing competition law and sector-specific regulations (healthcare products and regulated distribution channels).

The healthcare products sector (medicinal products for human and veterinary use, medical devices, cosmetics, etc.) is faced with significant competitive constraints resulting from ever-present economic and financial regulation.

Magenta helps clients, leading players in the pharmaceutical and medical device industry, with their relations with distributors and competitors. Magenta has developed a practice focusing on access to the healthcare product market and advises clients on preparing and negotiating their pricing and reimbursement applications.

Our work

Assisting pharmaceutical laboratories in drawing up and implementing commercial and pricing strategies in expectation of the launch of generic medicines.
Assisting and representing pharmaceutical laboratories in litigation against decisions by the French Economic Committee for Health Products (CEPS) (pricing, refused price increases).
Assisting in preparing and negotiating pricing and reimbursement applications for medicines and medical devices (standard market access process and exemptions, add-on list).
Assisting pharmaceutical laboratories in defining and implementing contingency practices/supply quotas.
Helping manufacturers with the development of relations with healthcare professionals in compliance with the no gift policy.
Assisting pharmaceutical and medical device laboratories in defining and implementing their commercial distribution policies (reimbursed and OTC products).
Assisting a cosmetic laboratory in defining and implementing its commercial policy in specialised channels via a selective distribution network.
Assisting medicine and medical device manufacturers in the tendering process to supply products to public healthcare institutions.

Our rankings

‘The Magenta team, led by Gaël Hichri, is a reference partner in the complex competition issues facing the health industries. The team is particularly responsive, and demonstrates creativity and flexibility allowing it to provide innovative solutions to its clients.’

Legal500 2024
Healthcare and life sciences

Excellent en Pharma, Santé et Biotechnologies – Droit de la distribution

Décideurs 2023
Droit de la distribution

Excellent en Pharma, Santé et Biotechnologies – Droit réglementaire

Décideurs 2023
Droit réglementaire